Canada’s COVID-19 Immunity Task Force (CITF) is supporting a new study to identify how many Canadians have been previously infected with SARS-CoV-2, the virus that causes COVID-19. The project, conducted by Statistics Canada, will be the first to use a nationally representative sample to reflect COVID-19 seroprevalence right across Canada at national, provincial, and [...]
The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund a Canadian Partnership for Tomorrow’s Health (CanPath) study looking at COVID-19 seroprevalence across Canada, with a particular focus on certain populations that are at higher risk of infection. CanPath is a national population health research platform that follows the health of 330,000 Canadians (or [...]
Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]
This study will analyze blood samples collected for standard testing in pregnancy from expectant women across Canada to help determine the spread of SARS-CoV-2 and when the virus entered Canada Today, Canada's COVID-19 Immunity Task Force (CITF) announces its support for a study of antenatal serum samples (using blood samples from standard tests from expectant women). This $3.1 [...]